Literature DB >> 3104046

Calcium-binding protein from human small intestine. Purification and characterization of a 10,000 molecular weight protein.

M Staun, H Sjöström, O Norén.   

Abstract

A calcium-binding protein (CaBP) was purified from human small intestinal mucosa by ammonium sulphate fractionation, gel filtration and chromatofocusing. Antibodies against CaBP were raised in rabbits and CaBP was then isolated from human intestinal cytosol by a one-step immunoadsorbent procedure. In polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate CaBP migrated as a single band corresponding to a molecular weight of 10,000. The calcium-binding ability of CaBP was demonstrated by increased electrophoretic mobility of CaBP in the presence of EDTA as demonstrated by immunoblotting of agarose gels. CaBP antibody showed no cross reaction with cytosolic proteins of duodenum from rat or pig. The present study suggests that molecular properties and distribution of human intestinal CaBP is comparable to those of intestinal CaBP detected in lower mammalian species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3104046     DOI: 10.1111/j.1365-2362.1986.tb02163.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Distribution of the 10,000 molecular weight calcium binding protein along the small and large intestine of man.

Authors:  M Staun
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

2.  Calcium-binding protein in human duodenal biopsies.

Authors:  M Staun; S Boesby; H Daugaard; S Jarnum
Journal:  Calcif Tissue Int       Date:  1988-04       Impact factor: 4.333

3.  Regulation of renal calbindin-D28K: the role of calcitonin.

Authors:  C Hemmingsen; M Staun; E Lewin; K Olgaard
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

Review 4.  Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.